HEADER TRANSFERASE 21-APR-05 1X29 TITLE CRYSTAL STRUCTURE OF E.COLI ASPAT COMPLEXED WITH N-PHOSPHOPYRIDOXYL-2- TITLE 2 METHYL-L-GLUTAMIC ACID COMPND MOL_ID: 1; COMPND 2 MOLECULE: ASPARTATE AMINOTRANSFERASE; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: TRANSAMINASE A, ASPAT; COMPND 5 EC: 2.6.1.1; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: ESCHERICHIA COLI; SOURCE 3 ORGANISM_TAXID: 562; SOURCE 4 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 5 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 6 EXPRESSION_SYSTEM_STRAIN: JM103; SOURCE 7 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 8 EXPRESSION_SYSTEM_PLASMID: PUC19 KEYWDS PLP-DEPENDENT ENZYME, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR M.GOTO REVDAT 4 13-MAR-24 1X29 1 REMARK REVDAT 3 11-OCT-17 1X29 1 REMARK REVDAT 2 24-FEB-09 1X29 1 VERSN REVDAT 1 14-JUN-05 1X29 0 JRNL AUTH M.M.ISLAM,M.GOTO,I.MIYAHARA,H.IKUSHIRO,K.HIROTSU,H.HAYASHI JRNL TITL BINDING OF C5-DICARBOXYLIC SUBSTRATE TO ASPARTATE JRNL TITL 2 AMINOTRANSFERASE: IMPLICATIONS FOR THE CONFORMATIONAL CHANGE JRNL TITL 3 AT THE TRANSALDIMINATION STEP. JRNL REF BIOCHEMISTRY V. 44 8218 2005 JRNL REFN ISSN 0006-2960 JRNL PMID 15938611 JRNL DOI 10.1021/BI050071G REMARK 2 REMARK 2 RESOLUTION. 2.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 49.33 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 2836614.420 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 98.6 REMARK 3 NUMBER OF REFLECTIONS : 47741 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.195 REMARK 3 FREE R VALUE : 0.232 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.100 REMARK 3 FREE R VALUE TEST SET COUNT : 4816 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.003 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.20 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.34 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.80 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 7128 REMARK 3 BIN R VALUE (WORKING SET) : 0.2450 REMARK 3 BIN FREE R VALUE : 0.2820 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 10.30 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 822 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.010 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 6046 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 52 REMARK 3 SOLVENT ATOMS : 191 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 28.20 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 34.70 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 2.11000 REMARK 3 B22 (A**2) : 2.11000 REMARK 3 B33 (A**2) : -4.21000 REMARK 3 B12 (A**2) : 3.02000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.24 REMARK 3 ESD FROM SIGMAA (A) : 0.23 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.30 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.27 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.006 REMARK 3 BOND ANGLES (DEGREES) : 1.300 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 22.50 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.780 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.210 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 1.870 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 22.990; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 20.330; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.37 REMARK 3 BSOL : 75.65 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : LMG.PARAM REMARK 3 PARAMETER FILE 4 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : TOP.WATER REMARK 3 TOPOLOGY FILE 3 : LMG.TOP REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1X29 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 25-APR-05. REMARK 100 THE DEPOSITION ID IS D_1000024287. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-OCT-03 REMARK 200 TEMPERATURE (KELVIN) : 293 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RU200 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV REMARK 200 INTENSITY-INTEGRATION SOFTWARE : R-AXIS REMARK 200 DATA SCALING SOFTWARE : R-AXIS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 47741 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.200 REMARK 200 RESOLUTION RANGE LOW (A) : 49.330 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.8 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.28 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.8 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 48.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.80 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 400, AMMONIUM SULFATE, PH 7.5, REMARK 280 VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 63 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z REMARK 290 3555 -X+Y,-X,Z REMARK 290 4555 -X,-Y,Z+1/2 REMARK 290 5555 Y,-X+Y,Z+1/2 REMARK 290 6555 X-Y,X,Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 40.69500 REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 40.69500 REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 40.69500 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 8190 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 27720 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -31.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 25 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 28 CG CD OE1 OE2 REMARK 470 LYS A 46 CG CD CE NZ REMARK 470 LYS A 90 CG CD CE NZ REMARK 470 LYS A 121 CG CD CE NZ REMARK 470 LYS A 126 CG CD CE NZ REMARK 470 GLN A 206 CG CD OE1 NE2 REMARK 470 LYS A 367 CG CD CE NZ REMARK 470 GLU A 368 CG CD OE1 OE2 REMARK 470 ARG B 25 CG CD NE CZ NH1 NH2 REMARK 470 ARG B 81 CG CD NE CZ NH1 NH2 REMARK 470 LYS B 90 CG CD CE NZ REMARK 470 LYS B 98 CG CD CE NZ REMARK 470 LYS B 126 CG CD CE NZ REMARK 470 GLU B 164 CG CD OE1 OE2 REMARK 470 GLN B 210 CG CD OE1 NE2 REMARK 470 GLU B 214 CG CD OE1 OE2 REMARK 470 LYS B 215 CG CD CE NZ REMARK 470 LYS B 248 CG CD CE NZ REMARK 470 LYS B 355 CG CD CE NZ REMARK 470 LYS B 367 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 92 140.87 -39.38 REMARK 500 TYR A 160 -45.43 -146.69 REMARK 500 ALA A 229 -76.05 -90.63 REMARK 500 ARG A 266 73.24 55.32 REMARK 500 ASN A 294 -78.29 -109.78 REMARK 500 SER A 296 -61.57 74.06 REMARK 500 ILE B 17 -65.94 -109.57 REMARK 500 TYR B 70 138.54 -37.76 REMARK 500 TYR B 160 -51.33 -158.52 REMARK 500 ALA B 229 -69.59 -95.63 REMARK 500 ARG B 266 74.93 52.60 REMARK 500 ASN B 294 -74.00 -108.39 REMARK 500 SER B 296 -64.53 69.07 REMARK 500 ASN B 347 35.42 -86.32 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PMG A 413 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PMG B 1413 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1X28 RELATED DB: PDB REMARK 900 THE SAME PROTEIN WITH PGU REMARK 900 RELATED ID: 1X2A RELATED DB: PDB REMARK 900 THE SAME PROTEIN WITH PDG DBREF 1X29 A 5 409 UNP P00509 AAT_ECOLI 1 396 DBREF 1X29 B 5 409 UNP P00509 AAT_ECOLI 1 396 SEQRES 1 A 396 MET PHE GLU ASN ILE THR ALA ALA PRO ALA ASP PRO ILE SEQRES 2 A 396 LEU GLY LEU ALA ASP LEU PHE ARG ALA ASP GLU ARG PRO SEQRES 3 A 396 GLY LYS ILE ASN LEU GLY ILE GLY VAL TYR LYS ASP GLU SEQRES 4 A 396 THR GLY LYS THR PRO VAL LEU THR SER VAL LYS LYS ALA SEQRES 5 A 396 GLU GLN TYR LEU LEU GLU ASN GLU THR THR LYS ASN TYR SEQRES 6 A 396 LEU GLY ILE ASP GLY ILE PRO GLU PHE GLY ARG CYS THR SEQRES 7 A 396 GLN GLU LEU LEU PHE GLY LYS GLY SER ALA LEU ILE ASN SEQRES 8 A 396 ASP LYS ARG ALA ARG THR ALA GLN THR PRO GLY GLY THR SEQRES 9 A 396 GLY ALA LEU ARG VAL ALA ALA ASP PHE LEU ALA LYS ASN SEQRES 10 A 396 THR SER VAL LYS ARG VAL TRP VAL SER ASN PRO SER TRP SEQRES 11 A 396 PRO ASN HIS LYS SER VAL PHE ASN SER ALA GLY LEU GLU SEQRES 12 A 396 VAL ARG GLU TYR ALA TYR TYR ASP ALA GLU ASN HIS THR SEQRES 13 A 396 LEU ASP PHE ASP ALA LEU ILE ASN SER LEU ASN GLU ALA SEQRES 14 A 396 GLN ALA GLY ASP VAL VAL LEU PHE HIS GLY CYS CYS HIS SEQRES 15 A 396 ASN PRO THR GLY ILE ASP PRO THR LEU GLU GLN TRP GLN SEQRES 16 A 396 THR LEU ALA GLN LEU SER VAL GLU LYS GLY TRP LEU PRO SEQRES 17 A 396 LEU PHE ASP PHE ALA TYR GLN GLY PHE ALA ARG GLY LEU SEQRES 18 A 396 GLU GLU ASP ALA GLU GLY LEU ARG ALA PHE ALA ALA MET SEQRES 19 A 396 HIS LYS GLU LEU ILE VAL ALA SER SER TYR SER LYS ASN SEQRES 20 A 396 PHE GLY LEU TYR ASN GLU ARG VAL GLY ALA CYS THR LEU SEQRES 21 A 396 VAL ALA ALA ASP SER GLU THR VAL ASP ARG ALA PHE SER SEQRES 22 A 396 GLN MET LYS ALA ALA ILE ARG ALA ASN TYR SER ASN PRO SEQRES 23 A 396 PRO ALA HIS GLY ALA SER VAL VAL ALA THR ILE LEU SER SEQRES 24 A 396 ASN ASP ALA LEU ARG ALA ILE TRP GLU GLN GLU LEU THR SEQRES 25 A 396 ASP MET ARG GLN ARG ILE GLN ARG MET ARG GLN LEU PHE SEQRES 26 A 396 VAL ASN THR LEU GLN GLU LYS GLY ALA ASN ARG ASP PHE SEQRES 27 A 396 SER PHE ILE ILE LYS GLN ASN GLY MET PHE SER PHE SER SEQRES 28 A 396 GLY LEU THR LYS GLU GLN VAL LEU ARG LEU ARG GLU GLU SEQRES 29 A 396 PHE GLY VAL TYR ALA VAL ALA SER GLY ARG VAL ASN VAL SEQRES 30 A 396 ALA GLY MET THR PRO ASP ASN MET ALA PRO LEU CYS GLU SEQRES 31 A 396 ALA ILE VAL ALA VAL LEU SEQRES 1 B 396 MET PHE GLU ASN ILE THR ALA ALA PRO ALA ASP PRO ILE SEQRES 2 B 396 LEU GLY LEU ALA ASP LEU PHE ARG ALA ASP GLU ARG PRO SEQRES 3 B 396 GLY LYS ILE ASN LEU GLY ILE GLY VAL TYR LYS ASP GLU SEQRES 4 B 396 THR GLY LYS THR PRO VAL LEU THR SER VAL LYS LYS ALA SEQRES 5 B 396 GLU GLN TYR LEU LEU GLU ASN GLU THR THR LYS ASN TYR SEQRES 6 B 396 LEU GLY ILE ASP GLY ILE PRO GLU PHE GLY ARG CYS THR SEQRES 7 B 396 GLN GLU LEU LEU PHE GLY LYS GLY SER ALA LEU ILE ASN SEQRES 8 B 396 ASP LYS ARG ALA ARG THR ALA GLN THR PRO GLY GLY THR SEQRES 9 B 396 GLY ALA LEU ARG VAL ALA ALA ASP PHE LEU ALA LYS ASN SEQRES 10 B 396 THR SER VAL LYS ARG VAL TRP VAL SER ASN PRO SER TRP SEQRES 11 B 396 PRO ASN HIS LYS SER VAL PHE ASN SER ALA GLY LEU GLU SEQRES 12 B 396 VAL ARG GLU TYR ALA TYR TYR ASP ALA GLU ASN HIS THR SEQRES 13 B 396 LEU ASP PHE ASP ALA LEU ILE ASN SER LEU ASN GLU ALA SEQRES 14 B 396 GLN ALA GLY ASP VAL VAL LEU PHE HIS GLY CYS CYS HIS SEQRES 15 B 396 ASN PRO THR GLY ILE ASP PRO THR LEU GLU GLN TRP GLN SEQRES 16 B 396 THR LEU ALA GLN LEU SER VAL GLU LYS GLY TRP LEU PRO SEQRES 17 B 396 LEU PHE ASP PHE ALA TYR GLN GLY PHE ALA ARG GLY LEU SEQRES 18 B 396 GLU GLU ASP ALA GLU GLY LEU ARG ALA PHE ALA ALA MET SEQRES 19 B 396 HIS LYS GLU LEU ILE VAL ALA SER SER TYR SER LYS ASN SEQRES 20 B 396 PHE GLY LEU TYR ASN GLU ARG VAL GLY ALA CYS THR LEU SEQRES 21 B 396 VAL ALA ALA ASP SER GLU THR VAL ASP ARG ALA PHE SER SEQRES 22 B 396 GLN MET LYS ALA ALA ILE ARG ALA ASN TYR SER ASN PRO SEQRES 23 B 396 PRO ALA HIS GLY ALA SER VAL VAL ALA THR ILE LEU SER SEQRES 24 B 396 ASN ASP ALA LEU ARG ALA ILE TRP GLU GLN GLU LEU THR SEQRES 25 B 396 ASP MET ARG GLN ARG ILE GLN ARG MET ARG GLN LEU PHE SEQRES 26 B 396 VAL ASN THR LEU GLN GLU LYS GLY ALA ASN ARG ASP PHE SEQRES 27 B 396 SER PHE ILE ILE LYS GLN ASN GLY MET PHE SER PHE SER SEQRES 28 B 396 GLY LEU THR LYS GLU GLN VAL LEU ARG LEU ARG GLU GLU SEQRES 29 B 396 PHE GLY VAL TYR ALA VAL ALA SER GLY ARG VAL ASN VAL SEQRES 30 B 396 ALA GLY MET THR PRO ASP ASN MET ALA PRO LEU CYS GLU SEQRES 31 B 396 ALA ILE VAL ALA VAL LEU HET PMG A 413 26 HET PMG B1413 26 HETNAM PMG N-({3-HYDROXY-2-METHYL-5-[(PHOSPHONOOXY)METHYL]PYRIDIN- HETNAM 2 PMG 4-YL}METHYL)-2-METHYL-L-GLUTAMIC ACID HETSYN PMG N-PYRIDOXYL-2-METHYL-L-GLUTAMIC ACID-5'-MONOPHOSPHATE FORMUL 3 PMG 2(C14 H21 N2 O9 P) FORMUL 5 HOH *191(H2 O) HELIX 1 1 ILE A 17 ASP A 27 1 11 HELIX 2 2 LEU A 50 GLU A 64 1 15 HELIX 3 3 ILE A 76 GLY A 89 1 14 HELIX 4 4 SER A 92 ASP A 97 1 6 HELIX 5 5 PRO A 106 THR A 123 1 18 HELIX 6 6 PRO A 141 ALA A 150 1 10 HELIX 7 7 ASP A 169 LEU A 177 1 9 HELIX 8 8 THR A 201 GLY A 216 1 16 HELIX 9 9 GLU A 234 ASP A 236 5 3 HELIX 10 10 ALA A 237 ALA A 245 1 9 HELIX 11 11 LEU A 262 ARG A 266 5 5 HELIX 12 12 ASP A 276 ALA A 293 1 18 HELIX 13 13 PRO A 299 ASN A 312 1 14 HELIX 14 14 ASN A 312 LYS A 344 1 33 HELIX 15 15 PHE A 350 GLN A 356 5 7 HELIX 16 16 THR A 366 GLY A 378 1 13 HELIX 17 17 ALA A 390 MET A 392 5 3 HELIX 18 18 ASN A 396 LEU A 409 1 13 HELIX 19 19 ILE B 17 ASP B 27 1 11 HELIX 20 20 LEU B 50 GLU B 64 1 15 HELIX 21 21 ILE B 76 GLY B 89 1 14 HELIX 22 22 SER B 92 ASP B 97 1 6 HELIX 23 23 PRO B 106 THR B 123 1 18 HELIX 24 24 PRO B 141 ALA B 150 1 10 HELIX 25 25 ASP B 169 ASN B 178 1 10 HELIX 26 26 THR B 201 GLY B 216 1 16 HELIX 27 27 GLY B 231 ALA B 245 1 14 HELIX 28 28 LEU B 262 ARG B 266 5 5 HELIX 29 29 ASP B 276 ALA B 293 1 18 HELIX 30 30 PRO B 299 ASN B 312 1 14 HELIX 31 31 ASN B 312 LYS B 344 1 33 HELIX 32 32 PHE B 350 GLN B 356 5 7 HELIX 33 33 THR B 366 GLY B 378 1 13 HELIX 34 34 ALA B 390 MET B 392 5 3 HELIX 35 35 ASN B 396 LEU B 409 1 13 SHEET 1 A 2 ILE A 33 ASN A 34 0 SHEET 2 A 2 VAL A 379 TYR A 380 1 O TYR A 380 N ILE A 33 SHEET 1 B 7 ALA A 100 THR A 105 0 SHEET 2 B 7 GLY A 268 VAL A 273 -1 O LEU A 272 N ARG A 101 SHEET 3 B 7 LEU A 250 SER A 255 -1 N VAL A 252 O THR A 271 SHEET 4 B 7 LEU A 218 PHE A 223 1 N PHE A 221 O ALA A 253 SHEET 5 B 7 VAL A 185 HIS A 189 1 N PHE A 188 O ASP A 222 SHEET 6 B 7 ARG A 129 ASN A 137 1 N TRP A 134 O LEU A 187 SHEET 7 B 7 GLU A 154 ALA A 159 1 O ARG A 156 N VAL A 135 SHEET 1 C 2 TYR A 161 ASP A 162 0 SHEET 2 C 2 THR A 167 LEU A 168 -1 O THR A 167 N ASP A 162 SHEET 1 D 2 PHE A 360 PHE A 362 0 SHEET 2 D 2 ARG A 386 ASN A 388 -1 O VAL A 387 N SER A 361 SHEET 1 E 2 ILE B 33 ASN B 34 0 SHEET 2 E 2 VAL B 379 TYR B 380 1 O TYR B 380 N ILE B 33 SHEET 1 F 7 ALA B 100 THR B 105 0 SHEET 2 F 7 GLY B 268 VAL B 273 -1 O LEU B 272 N ARG B 101 SHEET 3 F 7 LEU B 250 SER B 255 -1 N VAL B 252 O THR B 271 SHEET 4 F 7 LEU B 218 PHE B 223 1 N PHE B 221 O ALA B 253 SHEET 5 F 7 VAL B 185 HIS B 189 1 N PHE B 188 O ASP B 222 SHEET 6 F 7 ARG B 129 ASN B 137 1 N TRP B 134 O LEU B 187 SHEET 7 F 7 GLU B 154 ALA B 159 1 O ARG B 156 N VAL B 133 SHEET 1 G 2 TYR B 161 ASP B 162 0 SHEET 2 G 2 THR B 167 LEU B 168 -1 O THR B 167 N ASP B 162 SHEET 1 H 2 PHE B 360 PHE B 362 0 SHEET 2 H 2 ARG B 386 ASN B 388 -1 O VAL B 387 N SER B 361 CISPEP 1 ASN A 137 PRO A 138 0 0.06 CISPEP 2 ASN A 194 PRO A 195 0 0.72 CISPEP 3 ASN B 137 PRO B 138 0 0.20 CISPEP 4 ASN B 194 PRO B 195 0 0.66 SITE 1 AC1 17 ILE A 17 GLY A 38 GLY A 108 THR A 109 SITE 2 AC1 17 TRP A 140 ASN A 194 ASP A 222 TYR A 225 SITE 3 AC1 17 SER A 255 SER A 257 LYS A 258 ARG A 266 SITE 4 AC1 17 PHE A 360 ARG A 386 HOH A 425 TYR B 70 SITE 5 AC1 17 ARG B 292 SITE 1 AC2 18 TYR A 70 ARG A 292 ILE B 17 ILE B 37 SITE 2 AC2 18 GLY B 38 GLY B 107 GLY B 108 THR B 109 SITE 3 AC2 18 TRP B 140 ASN B 194 ASP B 222 TYR B 225 SITE 4 AC2 18 SER B 255 SER B 257 LYS B 258 ARG B 266 SITE 5 AC2 18 ARG B 386 HOH B1418 CRYST1 143.210 143.210 81.390 90.00 90.00 120.00 P 63 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.006983 0.004031 0.000000 0.00000 SCALE2 0.000000 0.008063 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012287 0.00000